Literature DB >> 19129714

Inhibin A production after gonadotropin stimulus: a new method to detect ovarian tissue in ovotesticular disorder of sex development.

L Steinmetz1, M N Rocha, C A Longui, D Damiani, V Dichtchekenian, N Setian, D Damiani.   

Abstract

BACKGROUND/AIMS: While laboratory methods for the detection of testicular tissue are well standardized, currently there is no available test to demonstrate the presence of ovarian tissue. We evaluated the effectiveness of gonadal stimulation with luteinizing hormone (LH)/follicle-stimulating hormone (FSH) for the detection of ovarian tissue in patients with disorders of sex development (DSD).
METHODS: Ten patients with congenital adrenal hyperplasia (CAH) as ovarian-positive controls, 10 with cryptorchidism (ovarian-negative controls), 13 patients with DSD of no defined etiology and 7 patients with ovotesticular DSD (true hermaphroditism, TH) were included in the study. They underwent a daily injection of both LH and FSH on 3 consecutive days. LH, FSH, estradiol, testosterone and inhibin A were measured before treatment, 24 h after the 1st dose and 24 h after the 3rd dose.
RESULTS: Estradiol increased in all CAH and TH patients, with a median value of 155.1 and 92.6 pg/ml, respectively, after the 3rd injection. Inhibin A also increased in all CAH and TH patients, with a median value of 70.4 and 32.2 pg/ml, respectively, after the 3rd injection. There was no change in these hormones in the other groups.
CONCLUSION: The LH/FSH stimulation test might be a useful method to detect the presence of ovarian tissue. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129714     DOI: 10.1159/000183898

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  6 in total

Review 1.  Management of disorders of sex development.

Authors:  Olaf Hiort; Wiebke Birnbaum; Louise Marshall; Lutz Wünsch; Ralf Werner; Tatjana Schröder; Ulla Döhnert; Paul-Martin Holterhus
Journal:  Nat Rev Endocrinol       Date:  2014-07-15       Impact factor: 43.330

2.  FSH Injections and Ultrasonography Determine Presence of Ovarian Components in the Evaluation of Ovotesticular Disorders of Sex Development.

Authors:  Shannon French; Luisa Rodriguez; Alan Schlesinger; Laurence McCullough; Jennifer Dietrich; John Hicks; Lefkothea Karaviti
Journal:  Int J Pediatr Endocrinol       Date:  2010-01-17

3.  The effect of 8-methoxypsoralen on pituitary-gonad axis and ovarian function in mice.

Authors:  Esmail Fattahi; Seyed Gholam Ali Jorsaraei; Mossa Gardaneh; Eisa Tahmasbpour Marzony
Journal:  Cell J       Date:  2013-08-24       Impact factor: 2.479

4.  UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development.

Authors:  S Faisal Ahmed; John C Achermann; Wiebke Arlt; Adam H Balen; Gerry Conway; Zoe L Edwards; Sue Elford; Ieuan A Hughes; Louise Izatt; Nils Krone; Harriet L Miles; Stuart O'Toole; Les Perry; Caroline Sanders; Margaret Simmonds; A Michael Wallace; Andrew Watt; Debbie Willis
Journal:  Clin Endocrinol (Oxf)       Date:  2011-07       Impact factor: 3.478

5.  Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (Revised 2015).

Authors:  S Faisal Ahmed; John C Achermann; Wiebke Arlt; Adam Balen; Gerry Conway; Zoe Edwards; Sue Elford; Ieuan A Hughes; Louise Izatt; Nils Krone; Harriet Miles; Stuart O'Toole; Les Perry; Caroline Sanders; Margaret Simmonds; Andrew Watt; Debbie Willis
Journal:  Clin Endocrinol (Oxf)       Date:  2015-08-13       Impact factor: 3.478

6.  Evaluation and treatment for ovotesticular disorder of sex development (OT-DSD) - experience based on a Chinese series.

Authors:  Yu Mao; Shaoji Chen; Ru Wang; Xuejun Wang; Daorui Qin; Yunman Tang
Journal:  BMC Urol       Date:  2017-03-28       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.